For allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, preemptive interferon-α (IFN-α) therapy is considered as a useful method to eliminate the minimal residual disease (MRD).
The significance of antibody-identified epitopes stimulating humoral alloimmunity is not well understood in the identification of non-permissive human leukocyte antigen (HLA) mismatching patterns in h
This is data for our article"Beyond MRD: The Interplay Between Early T-Cell Subset Dynamics and Donor-Recipient Gender in Predicting Post-Transplantation Recurrence". This dataset provides de-identifi
